产品中心 药物靶点和Fc受体 药物靶点

所有图片(1/1)

ALK-1/ACVRL1 Fc Chimera Protein, Mouse

SKR3,ALK-1,TSR-I

价格 2,960.00 1-2周
货号 UA010504
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 物种

    Mouse
  • 分子别名

    SKR3, ALK-1,TSR-I
  • Accession

    Q61288
  • 表达序列

    Asp23-Pro119, with C-terminal Human IgG1 Fc
  • 表达宿主

    HEK293
  • 分子量

    45-50 kDa (Reducing)
  • 纯度

    >95% by SDS-PAGE
  • 内毒素含量

    <0.1EU/μg
  • 标记

    Unconjugated
  • 标签

    Human Fc
  • 性状

    Lyophilized Powder
  • 缓冲体系

    PBS, pH7.4
  • 溶解方法

    Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
  • 储存条件

    · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
    · 3 months, -20 to -80℃ under sterile conditions after reconstitution.
    · 1 week, 2 to 8℃ under sterile conditions after reconstitution.
    · Please avoid repeated freeze-thaw cycles.
  • 文献引用

    1.Cindy Lora Gil. Bruno Larrivée. Alk1 haploinsufficiency causes glomerular dysfunction and microalbuminuria in diabetic mice. Scientific RepoRtS (2020) 10.

背景介绍
  • The Bone Morphogenetic Protein (BMP) receptor Activin receptor–like kinase 1 (Alk1), which is predominantly expressed in the vascular endothelium, has been shown to play a critical role in angiogenesis. Embryos lacking Alk1 die early during embryonic development due to impaired vascular remodeling and lack of perivascular cell coverage. In renal physiology, Alk1 has been suggested to play an important role in the regulation of extracellular matrix deposition, including collagen type I and fibronectin, and Alk1 heterozygosity has been associated with increased renal fibrosis in a mouse model of obstructive nephropathy, probably due to the decrease in the Alk1/Smad1 antifibrotic/protective signaling in renal fibroblasts.

  • 电泳

    • 1μg (R: reducing conditions, N: non-reducing conditions).

评论(0)